QCLS
NASDAQ · Pharmaceuticals
Q/C Technologies Inc
$3.89
-0.10 (-2.51%)
Open$3.89
Previous Close$3.99
Day High$4.14
Day Low$3.85
52W High$17.39
52W Low$2.50
Volume—
Avg Volume292.7K
Market Cap31.57M
P/E Ratio—
EPS$-35.49
SectorPharmaceuticals
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.12M | 5.83M | 5.05M |
| Net Income | 729.3K | 769.8K | 662.9K |
| Profit Margin | 11.9% | 13.2% | 13.1% |
| EBITDA | 1.12M | 1.08M | 875.0K |
| Free Cash Flow | 457.4K | 470.8K | 287.5K |
| Rev Growth | +22.0% | +12.4% | +6.3% |
| Debt/Equity | 0.30 | 0.26 | 0.28 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,107.08 | +0.45% | 40.9 | 1.03T |
| JNJ | Johnson & Johnson | $239.08 | +3.37% | 26.1 | 549.78B |
| MRK | Merck & Co. Inc. | $119.60 | +3.57% | 31.5 | 281.24B |
| PFE | Pfizer Inc. | $24.72 | -1.44% | 19.2 | 143.68B |
| BMY | Bristol-Myers Squibb Co | $55.53 | +1.52% | 18.5 | 110.27B |
| ZTS | Zoetis Inc | $76.84 | +1.25% | 12.5 | 33.00B |